Literature DB >> 19940734

Revision surgery following cervical laminoplasty: etiology and treatment strategies.

Gabriel Liu1, Jacob M Buchowski, Torphong Bunmaprasert, Jin S Yeom, Hongxing Shen, K Daniel Riew.   

Abstract

STUDY
DESIGN: Retrospective review of prospectively collected data.
OBJECTIVE: To identify the cause of failed open-door laminoplasty and to describe the surgical strategies for revision surgery. SUMMARY OF BACKGROUND DATA: Although laminoplasty has become popular, few articles have addressed the cause of failed cervical laminoplasty requiring revision surgery.
METHODS: All patients who required revision surgery following open-door cervical laminoplasty were identified. Clinical data, method of surgical revision, time between surgeries, Nurick grade, radiologic parameters, and complications were analyzed. Laminoplasty failures were classified into 3 categories: "technique related," "inadequate symptomatic relief after treatment," or "recurrence of symptoms due to disease progression."
RESULTS: A total of 130 patients underwent cervical laminoplasty over a 10-year period (1996-2006), and 12 patients (9.2%) required revision surgery. The mean age was 50.7 years at the time of the index laminoplasty (range, 34-67 years) and 51.8 years (range, 35-70 years) at the time of the revision surgery. Mean duration of symptoms was 7.3 months before the index procedure (range, 2-17 months) and 5.6 months (range, 1-14 months) before revision surgery. The mean time interval between the index procedure and revision surgery was 16.6 months (range, 4-43 months). Of the 12 patients who required revision surgery, 5 had global lordosis of <10 degrees, 4 developed local kyphosis >13 degrees, and 5 had increased degenerative spondylolisthesis. Nonmyelopathic causes resulted in 50% of the revision surgery. Of 12 patients, 3 (25%) required revision surgery due to technique-related factors; 1 (8%) required surgery due to inadequate symptomatic relief after treatment; and 8 (67%) required revision surgery due to disease progression.
CONCLUSION: Of the 130 patients who underwent cervical laminoplasty over a 10-year period, 12 patients (9.2%) required revision surgery. Although laminoplasty is generally successful, failures due to disease progression, technique-related factors, and inadequate symptomatic relief after treatment can occur. Patients should, therefore, be counseled regarding the potential need for revision surgery when undergoing open-door laminoplasty.

Entities:  

Mesh:

Year:  2009        PMID: 19940734     DOI: 10.1097/BRS.0b013e3181b11ee1

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Laminoplasty using Twinfix suture anchors to maintain cervical canal expansion.

Authors:  Hai-Long Yu; Liang-Bi Xiang; Jun Liu; Yu Chen; Ming Yu; Yan Cao
Journal:  Eur Spine J       Date:  2010-05-07       Impact factor: 3.134

2.  Cervical laminoplasty for multilevel cervical myelopathy.

Authors:  Murali Krishna Sayana; Hassan Jamil; Ashley Poynton
Journal:  Adv Orthop       Date:  2011-10-02

3.  Prevalence of complications after surgery in treatment for cervical compressive myelopathy: A meta-analysis for last decade.

Authors:  Tao Wang; Xiao-Ming Tian; Si-Kai Liu; Hui Wang; Ying-Ze Zhang; Wen-Yuan Ding
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  The cervical sagittal curvature change in patients with or without PCSM after laminoplasty.

Authors:  Shengjun Qian; Zhan Wang; Ying Ren; Ian Chew; Guangyao Jiang; Wanli Li; Weishan Chen
Journal:  Front Surg       Date:  2022-08-08

5.  Incidence and Risk Factors for Late Neurologic Deterioration after C3-C6 Laminoplasty for Cervical Spondylotic Myelopathy.

Authors:  Hironobu Sakaura; Toshitada Miwa; Yusuke Kuroda; Tetsuo Ohwada
Journal:  Global Spine J       Date:  2015-06-24

6.  Efficacy of Laminoplasty in Patients with Cervical Kyphosis.

Authors:  Shengjun Qian; Zhan Wang; Guangyao Jiang; Zhengkuan Xu; Weishan Chen
Journal:  Med Sci Monit       Date:  2018-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.